HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

The Sunscreen Innovation Act passes with President Obama’s autograph; movement to ban cosmetic animal-testing in Australia gains momentum. More news in brief.

You may also be interested in...



FDA Needs Industry Work Plan Before Granting Sunscreen Ingredient Rulemaking Deferrals

Industry must provide the agency with a draft plan by 3 Sept. describing the work it intends to conduct to support the generally recognized safety and effectiveness of eight chemical UV filters commonly used on today’s market. Without rulemaking deferrals, the active ingredients’ fate is uncertain as the 26 Nov. statutory deadline for a final OTC sunscreen drug monograph draws near.

ASA Ruling On IMEDEEN Beauty Drink Illustrates Nutricosmetic Challenge In EU

If you're in the nutricosmetics game, the EU is the place to be, market researchers suggest. However, European regulations for health claims on food products put nutricosmetic brands in a tight spot.

Implied Claims For Gold Collagen Liquid Supplement Hard To Swallow – ASA

The UK's advertising self-regulatory authority finds numerous shortcomings in Minerva Research Labs' clinical study evidence for implied skin and collagen benefit claims in advertising for its Gold Collagen drinkable supplement. The case suggests that substantiating efficacy claims in regulatory settings may be as much a challenge for nutricosmetic marketers as convincing consumers that their products work.

Related Content

Related Companies

UsernamePublicRestriction

Register

RS019313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel